Search Results - "Lindman, Ylva"

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity by Maurer, Patrik, Jennings, Gary T., Willers, Jörg, Rohner, Franziska, Lindman, Ylva, Roubicek, Kirsten, Renner, Wolfgang A., Müller, Philipp, Bachmann, Martin F.

“…Nicotine is the principal addictive component in tobacco, and following uptake acts in the central nervous system. The smoking‐cessation efforts of most…”
Get full text

Preclinical Efficacy and Toxicology Studies of APR-246, a Novel Anticancer Compound Currently In Clinical Trials for Refractory Hematological Malignancies and Prostate Cancer by Mohell, Nina, Liljebris, Charlotta, Alfredsson, Jessica, Lindman, Ylva, Uustalu, Maria, Uhlin, Thomas, Linderholm, Mats R.H., Wiman, Klas G.

“…Abstract 1806 The tumor suppressor protein p53 is a transcription factor involved in cell cycle arrest, senescence and apoptosis. The p53 gene is frequently…”
Get full text

Further Preclinical Studies with APR-246, a Novel Anticancer Compound Currently in Clinical Trials for Hematological Malignancies and Prostate Cancer by Mohell, Nina, Liljebris, Charlotta, Alfredsson, Jessica, Lindman, Ylva, Uustalu, Maria, Wiman, Klas G, Uhlin, Thomas

“…Abstract 3773 Poster Board III-709 The tumor suppressor protein p53 induces cell cycle arrest and/or apoptosis in response to various forms of cellular stress,…”
Get full text